Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102013653 | 10201365 | 3 | F | 20130418 | 20160705 | 20140528 | 20160712 | EXP | JP-SA-2014SA068402 | AVENTIS | 16.00 | YR | T | M | Y | 48.00000 | KG | 20160712 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102013653 | 10201365 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | UNKNOWN | 103869 | 120 | MG | POWDER FOR SOLUTION FOR INFUSION | QD | ||||||
| 102013653 | 10201365 | 2 | C | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 102013653 | 10201365 | 3 | C | PRIDOL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 0 | ||||||||||||
| 102013653 | 10201365 | 4 | C | NEOPHAGEN | GLYCYRRHIZIN | 1 | 0 | ||||||||||||
| 102013653 | 10201365 | 5 | C | GRANISETRON | GRANISETRON | 1 | 0 | ||||||||||||
| 102013653 | 10201365 | 6 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 102013653 | 10201365 | 7 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 0 | ||||||||||||
| 102013653 | 10201365 | 8 | C | URSO | URSODIOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102013653 | 10201365 | 1 | Bone marrow conditioning regimen |
| 102013653 | 10201365 | 2 | Premedication |
| 102013653 | 10201365 | 3 | Prophylaxis |
| 102013653 | 10201365 | 4 | Prophylaxis |
| 102013653 | 10201365 | 5 | Prophylaxis |
| 102013653 | 10201365 | 6 | Prophylaxis against graft versus host disease |
| 102013653 | 10201365 | 7 | Prophylaxis against graft versus host disease |
| 102013653 | 10201365 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102013653 | 10201365 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102013653 | 10201365 | Cytomegalovirus viraemia | |
| 102013653 | 10201365 | Engraftment syndrome | |
| 102013653 | 10201365 | Febrile neutropenia | |
| 102013653 | 10201365 | Liver disorder | |
| 102013653 | 10201365 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102013653 | 10201365 | 1 | 20130418 | 20130419 | 0 | |
| 102013653 | 10201365 | 2 | 20130420 | 20130421 | 0 | |
| 102013653 | 10201365 | 3 | 20130418 | 20130419 | 0 | |
| 102013653 | 10201365 | 4 | 20130419 | 20130423 | 0 | |
| 102013653 | 10201365 | 5 | 20130418 | 20130421 | 0 | |
| 102013653 | 10201365 | 6 | 20130424 | 20130429 | 0 | |
| 102013653 | 10201365 | 7 | 20130422 | 20130527 | 0 | |
| 102013653 | 10201365 | 8 | 20130417 | 0 |